Quick Answer
Strata Critical Medical, Inc. reported Total Revenue of $197.14 million for fiscal year 2025.
Strata Critical Medical, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $197.14M +34.3% |
$146.82M -34.8% |
$225.18M +54.1% |
$146.12M +189.2% |
$50.53M +115.6% |
$23.43M -24.9% |
| Revenue (ASC 606) | $197.14M +34.3% |
$146.82M -34.8% |
$225.18M +54.1% |
$146.12M +189.2% |
$50.53M +115.6% |
$23.43M -24.9% |
| Net Income | $41.35M +251.4% |
-$27.31M +51.3% |
-$56.08M -105.7% |
-$27.26M +31.9% |
-$40.05M -294.2% |
-$10.16M +6.3% |
| Diluted EPS | $0.50 +242.9% |
-$0.35 +53.9% |
-$0.76 -100.0% |
-$0.38 +59.1% |
-$0.93 -132.5% |
-$0.40 +7.0% |
| Total Assets | $325.47M +26.8% |
$256.68M -13.0% |
$294.94M -9.3% |
$325.02M -5.3% |
$343.39M +1838.4% |
$17.71M -93.6% |
| Cash and Equivalents | $30.97M +68.5% |
$18.38M -34.1% |
$27.87M -32.6% |
$41.34M +494.6% |
$6.95M -42.8% |
$12.16M -45.2% |
| Stockholders Equity | $279.07M +25.7% |
$221.94M -5.3% |
$234.30M -14.6% |
$274.49M -5.7% |
$291.23M +2528.4% |
$11.08M |
| Operating Income | -$22.35M +0.8% |
-$22.52M +66.9% |
-$68.12M -27.3% |
-$53.53M -122.2% |
-$24.09M -132.6% |
-$10.36M +10.2% |
| Gross Profit | $41.13M +39.0% |
$29.59M | — | — | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $49.30M | +36.7% | -30.4% |
| Revenue (ASC 606) | September 30, 2025 | $49.30M | +36.7% | -30.4% |
| Net Income | September 30, 2025 | $57.42M | +3038.4% | +1634.0% |
| Diluted EPS | September 30, 2025 | $0.70 | +2433.3% | +1500.0% |
| Total Assets | September 30, 2025 | $335.08M | +18.4% | +29.9% |
| Cash and Equivalents | September 30, 2025 | $22.75M | +13.6% | -61.3% |
| Stockholders Equity | September 30, 2025 | $283.00M | +21.2% | +26.8% |
| Operating Income | September 30, 2025 | -$5.62M | +20.7% | -13.5% |
- Strata Critical Medical, Inc. reported Total Revenue of $197.14 million for fiscal year 2025.
- Strata Critical Medical, Inc. showed an increase of +34.3% in Total Revenue compared to the prior fiscal year.
- Strata Critical Medical, Inc. reported Revenue (ASC 606) of $197.14 million for fiscal year 2025.
- Strata Critical Medical, Inc. showed an increase of +34.3% in Revenue (ASC 606) compared to the prior fiscal year.
- Strata Critical Medical, Inc. reported Net Income of $41.35 million for fiscal year 2025.
- Strata Critical Medical, Inc. showed an increase of +251.4% in Net Income compared to the prior fiscal year.
- Strata Critical Medical, Inc. reported Diluted EPS of $0.50 per share for fiscal year 2025.
- Strata Critical Medical, Inc. showed an increase of +242.9% in Diluted EPS compared to the prior fiscal year.
- Strata Critical Medical, Inc. reported Total Assets of $325.47 million for fiscal year 2025.
- Strata Critical Medical, Inc. showed an increase of +26.8% in Total Assets compared to the prior fiscal year.
- Strata Critical Medical, Inc. reported Cash and Equivalents of $30.97 million for fiscal year 2025.
- Strata Critical Medical, Inc. showed an increase of +68.5% in Cash and Equivalents compared to the prior fiscal year.
- Strata Critical Medical, Inc. reported Stockholders Equity of $279.07 million for fiscal year 2025.
- Strata Critical Medical, Inc. showed an increase of +25.7% in Stockholders Equity compared to the prior fiscal year.
- Strata Critical Medical, Inc. reported Operating Income of -$22.35 million for fiscal year 2025.
- Strata Critical Medical, Inc. showed an increase of +0.8% in Operating Income compared to the prior fiscal year.
- Strata Critical Medical, Inc. reported Gross Profit of $41.13 million for fiscal year 2025.
- Strata Critical Medical, Inc. showed an increase of +39.0% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: